CERA

Close Menu

Donate

Donate to CERA

Subscribe

Get monthly updates

Clinical trials

Take part in research
Close Close

Our research is bringing hope to people affected by vision loss and blindness

Donate Now

2026 Matched Giving Campaign

Help Poppy keep looking forward

Donate today and your investment into sight-saving research will be doubled – meaning you can bring hope twice as close for children like Poppy.

Read and listen

Visionary magazine – Spring 2026

In our latest edition, we celebrate 30 years of CERA and explore inherited retinal diseases and the research bringing treatments closer. Read online, download an accessible PDF or listen to the audio.

Watch

17th Annual Gerard Crock Lecture

Watch Professor Pete Williams present: From bench to bedside (and back again): Protecting and repairing the retina and optic nerve in glaucoma

Cerulea Clinical Trials

Cerulea Clinical Trials is CERA’s not-for-profit clinical trials centre.

Learn how Cerulea is transforming the delivery of ophthalmic clinical trials, increasing community access to sight-saving therapies and delivering excellence for clinicians, trial participants and sponsors.

Read more

Take part in research

Help shape the future of vision research by taking part in a clinical study.

Find out how you can take part in studies at CERA and Cerulea Clinical Trials for eye conditions including age-related macular degeneration, corneal conditions, diabetic retinopathy, glaucoma and inherited retinal disease.

Learn more

Latest News
News

Eye research joins MND fight

26 October 2026

Discoveries emerging from research to prevent vision loss from glaucoma are now being applied to the fight against motor neurone disease.
News

Research reveals retina’s power grid

03 September 2026

New research reveals how blood flow in the eye is directed to the cells that need it most – and what happens to our vision when that system breaks down. 
Stories

Legacy of sight honoured

03 September 2026

CERA has recognised the enormous legacy of long-time supporter Peter Clemenger AO with the unveiling of the Clemenger Seminar Room.
News

New spin-out company to develop precision treatments for genetic blindness

17 July 2026

CERA’s newest spin out company Adara Bio is forging key partnerships to support its work to develop precision treatments for blindness caused by inherited retinal disease (IRD).

Eye-news emails are sent to subscribers once a month

Newsletter Subscribe
Receive Appeals
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.